Ureteral Stents

Global Ureteral Stents Market to Reach ## by 2030

The global market for Ureteral Stents estimated at ## in the year 2024, is expected to reach ## by 2030, growing at a CAGR of 0.0% over the analysis period 2024-2030.

Global Ureteral Stents Market – Key Trends & Drivers Summarized

Is the Rise in Urological Disorders Driving a New Era of Stent-Based Interventions?

The growing global incidence of urological disorders is significantly increasing the demand for ureteral stents, making them a critical tool in modern urological care. Ureteral stents are thin, flexible tubes inserted into the ureters to relieve obstructions, facilitate urine drainage from the kidney to the bladder, and support healing post-surgery. With the rising prevalence of conditions such as kidney stones (urolithiasis), benign prostatic hyperplasia (BPH), strictures, tumors, and post-surgical edema, the use of ureteral stents has become increasingly routine across hospitals and urology clinics. In particular, the global upsurge in lifestyle-related metabolic disorders like obesity and diabetes is linked to higher rates of stone formation, thus indirectly fueling demand for temporary or indwelling stenting procedures. As minimally invasive endourological procedures such as ureteroscopy, percutaneous nephrolithotomy (PCNL), and laparoscopic surgeries become more common, ureteral stents are increasingly utilized to ensure post-operative drainage and prevent complications. Additionally, the aging population—which is more susceptible to urinary tract dysfunction and malignancies—is expanding the patient base requiring long-term stent support. As awareness of urinary health grows and diagnostic technologies improve, more cases are being identified earlier, creating a larger pool of candidates for timely stenting interventions.

How Are Material Innovations and Patient-Centric Designs Elevating Stent Performance?

Technological advancements in stent design, materials, and coatings are significantly improving patient outcomes, tolerability, and procedural efficiency. Traditional stents made of polyurethane or silicone are being enhanced or replaced with new-generation materials that offer superior biocompatibility, flexibility, and resistance to encrustation and infection. Hydrophilic coatings, anti-microbial layers, and drug-eluting stents are gaining popularity for their ability to reduce irritation, discomfort, and risk of urinary tract infections (UTIs)—common complications associated with long-term stent use. Moreover, biodegradable stents are gaining traction as they eliminate the need for removal procedures, reducing patient burden and overall healthcare costs. These stents naturally dissolve over time, making them ideal for short-term use and post-operative recovery in stone and stricture management. In addition, manufacturers are investing in patient-friendly innovations such as stents with extraction strings, magnetic retrieval tips, and customizable lengths and shapes tailored to anatomical variability. Smart stent prototypes equipped with biosensors and wireless monitoring capabilities are in the pipeline, enabling real-time tracking of stent position, flow rates, and obstruction detection. These innovations are not only enhancing clinical efficiency but also elevating the overall patient experience, which is crucial as elective urological procedures shift toward outpatient settings and patient expectations for comfort and convenience rise.

Is Outpatient Urological Care Shaping the Next Phase of Stent Utilization?

The global shift toward outpatient care and same-day surgical procedures is playing a pivotal role in reshaping the ureteral stents market. The widespread adoption of minimally invasive urological interventions has made procedures such as stone removal and stricture dilation faster, safer, and more suitable for outpatient environments. Ureteral stents, as an essential post-procedure tool, are benefiting directly from this shift. Ambulatory surgical centers and day-care urology units are increasingly equipped to perform stent placements and removals with rapid turnaround and lower costs compared to inpatient facilities. This trend is not only boosting procedural volumes but also driving demand for easy-to-insert, pre-assembled stent kits and single-use instrumentation. Additionally, the emergence of stent tracking systems and mobile health apps is streamlining follow-up care and reducing the risk of forgotten or retained stents—a historically overlooked complication. The growing collaboration between device manufacturers and outpatient surgical networks is facilitating the design and delivery of products tailored to high-throughput, cost-sensitive environments. The movement toward outpatient urology also intersects with broader healthcare trends such as value-based care and patient-centric treatment pathways, positioning ureteral stents as both a clinical necessity and an opportunity for care optimization. This alignment between surgical innovation and patient flow management is reinforcing the role of stents as an integral part of evolving urological practice.

What Is Driving the Growth of the Global Ureteral Stents Market?

The growth in the ureteral stents market is driven by a combination of clinical demand, demographic factors, technological progress, and evolving care delivery models. One of the primary drivers is the rising global prevalence of urolithiasis and other obstructive urological conditions, which necessitate intervention using temporary or permanent stents. The widespread adoption of minimally invasive surgical techniques has further elevated the need for supportive stenting post-procedure, especially in the context of outpatient and ambulatory settings. Advances in stent design—such as drug-eluting coatings, bioabsorbable materials, and anti-reflux valves—are significantly improving device performance and reducing complication rates, making stents more appealing to both patients and providers. The aging population, particularly in developed markets, is contributing to increased volumes of chronic urinary dysfunction cases requiring long-term stenting. Improved healthcare infrastructure and awareness in emerging markets are also boosting procedural rates and device adoption. Additionally, government and private payer support for urological care—combined with innovations in supply chain and product accessibility—are accelerating market penetration. The ongoing trend of personalized medicine is pushing manufacturers to offer anatomically tailored, patient-specific solutions. As these forces converge, the ureteral stents market is poised for continued expansion, supported by the dual imperatives of clinical efficacy and improved patient quality of life.

SCOPE OF STUDY:

The report analyzes the Ureteral Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Material (Metallic Ureteral Stents, Polymer Ureteral Stents); Application (Kidney Stones, Kidney Transplantation, Tumors, Urinary Incontinence, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Allium Medical
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Coloplast
• Cook Medical
• CR Bard (a subsidiary of BD)
• EndoMed Systems
• Gohar Shafa
• Manish Medi Innovation
• Med pro Medical
• Medical Engineering Corporation
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Olympus Corporation
• OptiMed
• Pnn Medical A/S
• Plasti-med
• Rocamed
• SILMAG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.